Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Liabilities (Quarterly): 33.52M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 33.52M |
| June 30, 2024 | 37.06M |
| March 31, 2024 | 34.67M |
| December 31, 2023 | 53.60M |
| September 30, 2023 | 54.94M |
| June 30, 2023 | 63.67M |
| March 31, 2023 | 67.37M |
| December 31, 2022 | 126.17M |
| September 30, 2022 | 125.27M |
| June 30, 2022 | 161.73M |
| March 31, 2022 | 90.43M |
| December 31, 2021 | 96.27M |
| September 30, 2021 | 82.19M |
| June 30, 2021 | 83.29M |
| March 31, 2021 | 73.26M |
| December 31, 2020 | 78.63M |
| September 30, 2020 | 113.81M |
| June 30, 2020 | 256.82M |
| March 31, 2020 | 151.07M |
| December 31, 2019 | 138.55M |
| September 30, 2019 | 115.41M |
| June 30, 2019 | 108.60M |
| March 31, 2019 | 110.20M |
| December 31, 2018 | 44.08M |
| September 30, 2018 | 36.99M |
| Date | Value |
|---|---|
| June 30, 2018 | 37.43M |
| March 31, 2018 | 60.57M |
| December 31, 2017 | 44.75M |
| September 30, 2017 | 41.56M |
| June 30, 2017 | 35.32M |
| March 31, 2017 | 47.37M |
| December 31, 2016 | 50.33M |
| September 30, 2016 | 47.57M |
| June 30, 2016 | 41.90M |
| March 31, 2016 | 40.07M |
| December 31, 2015 | 37.91M |
| September 30, 2015 | 37.39M |
| June 30, 2015 | 20.75M |
| March 31, 2015 | 14.43M |
| December 31, 2014 | 20.25M |
| September 30, 2014 | 17.49M |
| June 30, 2014 | 19.88M |
| March 31, 2014 | 22.48M |
| December 31, 2013 | 35.38M |
| September 30, 2013 | 25.80M |
| June 30, 2013 | 21.32M |
| March 31, 2013 | 17.78M |
| December 31, 2012 | 10.28M |
| September 30, 2012 | 13.20M |
| June 30, 2012 | 12.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
33.52M
Minimum
Sep 2024
256.82M
Maximum
Jun 2020
96.12M
Average
82.74M
Median
Total Liabilities (Quarterly) Benchmarks
| Novavax Inc | 2.239B |
| Baxter International Inc | 18.73B |
| AIM ImmunoTech Inc | 10.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.06M |
| Shareholders Equity (Quarterly) | 73.54M |